TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive Congressional committee investigates former NCI Director Richard Klausner’s role in $40 million Harvard contract; NIH begins internal review. Klausner: investigation casts “strange innuendoes.” Text of committee’s letter. November 14, 2003
TCL Archive In Brief: First CREG Announcement Due In Late April For In Vitro Carcinogen Test Improvements March 21, 1975
TCL Archive NIH to ban consulting by top officials, limit outside work by other employees. June 25, 2004
